Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent
Interleukin- (IL-) 35 is a member of the IL-12 cytokine family and a heterodimeric protein formed by Epstein-Barr-induced gene 3 (EBI3) and IL-12p35. Emerging evidence shows that IL-35 is a key player in the regulation of cellular communication, differentiation, and inflammation. Altered IL-35 expre...
Saved in:
| Main Authors: | Peng Gao, Zhenzhong Su, Xuejiao Lv, Jie Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/5931865 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Would We Prevent Asthma with Potential Therapeutic Strategies?
by: Dhamend Lutchman
Published: (2008-08-01) -
Immunomodulatory roles of butyrate in asthma: mechanisms and therapeutic potentials
by: Chao Liu, et al.
Published: (2025-08-01) -
Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases
by: Zhongyu Fan, et al.
Published: (2025-02-01) -
Oxidative Stress in Pediatric Asthma: Sources, Mechanisms, and Therapeutic Potential of Antioxidants
by: Yanhua Han, et al.
Published: (2025-02-01) -
YAP as a potential therapeutic target for myofibroblast formation in asthma
by: Yanrong Guo, et al.
Published: (2025-02-01)